treasury shares of Baht 511.96 million. - 9 - (2.7) Financial Ratios Financial Ratios As at June 30, 2020 As at December 31, 2019 Current Ratio (Times) 1.08 1.64 Quick Ratio (Times) 0.49 0.65 Cash flow
. This excludes the Corpus Christi PTA and PET integrated JV project and Dupont Teijin Films project which are both awaiting regulatory approvals. Indorama Ventures 2nd Quarter 2018 MD&A 14 Forward-looking
Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2018 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and
Management’s Discussion and Analysis (MD&A) Consolidated Financial Results: 2018 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and
Results: 1Q19 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 2 of 15 CPN continues to emphasize on
Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 2 of 14 Major Events in 2Q19 New Retail Development to Become the “Center of Life” “Central i-City
, IBD/E would be 1.58x. Consolidated Q2/2018 2017 Quick Ratio (Times) 0.79 0.91 Interest-bearing Debt to Equity (Times) 1.65 1.13 LQSF Q2/2561 2560 Quick Ratio (Times) 0.60 n.a. Interest-bearing Debt to
Analysis (MD&A) Consolidated Financial Results: 3Q18 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 2 of 15
Analysis (MD&A) Consolidated Financial Results: 3Q19 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 2 of 16
Discussion and Analysis (MD&A) Consolidated Financial Results: 1Q20 Major Events Performance Business Plan Document Quick Link Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A